GlucoTrack to participate in FORGETDIABETES initiative

Glucotrack (GCTK) will participate in the FORGETDIABETES bionic pancreas initiative that will develop a long-term, automated insulin delivery system that will enable optimal glucose control without patient intervention. FORGETDIABETES is funded by the European Union’s Horizon 2020 research and innovation program, a multi-year funding program with EUR 75 Billion to support initiatives ranging from basic research to innovative product development. The groundbreaking FORGETDIABETES initiative is dedicated to developing a bionic invisible pancreas, which will free people with type 1 diabetes from therapeutic actions and the related psychological burden. Glucotrack’s Continuous Blood Glucose Monitor will provide real-time glucose readings to drive insulin delivery decisions for the bionic pancreas system. Despite significant advancements in diabetes technology, such as subcutaneous continuous glucose sensors and insulin pumps, daily management remains a substantial burden for many people living with diabetes. The FORGETDIABETES initiative aims to alleviate this burden by developing a groundbreaking bionic pancreas technology. This innovative solution seeks to transform diabetes from a disease that requires constant attention into a more manageable lifestyle condition, much like wearing long-term contact lenses. By simplifying diabetes management, the bionic pancreas has the potential to revolutionize the lives of countless individuals, allowing them to focus on their daily activities without the constant worry and interruptions associated with traditional diabetes care.